Siemens Healthineers Valuation
| SMMNY Stock | USD 28.03 0.55 2.00% |
At this time, the company appears to be fairly valued. Siemens Healthineers has a current Real Value of $27.95 per share. The regular price of the company is $28.03. Our model measures the value of Siemens Healthineers from inspecting the company fundamentals such as Shares Outstanding of 2.24 B, operating margin of 0.13 %, and Return On Equity of 0.11 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Siemens Healthineers' price fluctuation is very steady at this time. Calculation of the real value of Siemens Healthineers is based on 3 months time horizon. Increasing Siemens Healthineers' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Siemens Healthineers is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Siemens Pink Sheet. However, Siemens Healthineers' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 28.03 | Real 27.95 | Hype 28.03 | Naive 28.22 |
The intrinsic value of Siemens Healthineers' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Siemens Healthineers' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Siemens Healthineers AG helps investors to forecast how Siemens pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Siemens Healthineers more accurately as focusing exclusively on Siemens Healthineers' fundamentals will not take into account other important factors: Siemens Healthineers Total Value Analysis
Siemens Healthineers AG is at this time estimated to have takeover price of 59.39 B with market capitalization of 63.44 B, debt of 15 M, and cash on hands of 1.37 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Siemens Healthineers fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
59.39 B | 63.44 B | 15 M | 1.37 B |
Siemens Healthineers Investor Information
The book value of the company was at this time reported as 8.39. The company has Price/Earnings To Growth (PEG) ratio of 2.57. Siemens Healthineers last dividend was issued on the 16th of February 2023. Based on the key indicators related to Siemens Healthineers' liquidity, profitability, solvency, and operating efficiency, Siemens Healthineers AG is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Siemens Healthineers Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Siemens Healthineers has an asset utilization ratio of 44.26 percent. This suggests that the Company is making $0.44 for each dollar of assets. An increasing asset utilization means that Siemens Healthineers AG is more efficient with each dollar of assets it utilizes for everyday operations.Siemens Healthineers Profitability Analysis
The company reported the revenue of 21.71 B. Net Income was 2.04 B with profit before overhead, payroll, taxes, and interest of 8.14 B.About Siemens Healthineers Valuation
Our relative valuation model uses a comparative analysis of Siemens Healthineers. We calculate exposure to Siemens Healthineers's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Siemens Healthineers's related companies.Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. SIEMENS HEALTHINEERS is traded on OTC Exchange in the United States.
8 Steps to conduct Siemens Healthineers' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Siemens Healthineers' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Siemens Healthineers' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Siemens Healthineers' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Siemens Healthineers' revenue streams: Identify Siemens Healthineers' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Siemens Healthineers' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Siemens Healthineers' growth potential: Evaluate Siemens Healthineers' management, business model, and growth potential.
- Determine Siemens Healthineers' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Siemens Healthineers' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Siemens Healthineers Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.1 B | |
| Quarterly Earnings Growth Y O Y | -0.098 | |
| Forward Price Earnings | 24.5098 | |
| Retained Earnings | 894 M |
Additional Tools for Siemens Pink Sheet Analysis
When running Siemens Healthineers' price analysis, check to measure Siemens Healthineers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Siemens Healthineers is operating at the current time. Most of Siemens Healthineers' value examination focuses on studying past and present price action to predict the probability of Siemens Healthineers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Siemens Healthineers' price. Additionally, you may evaluate how the addition of Siemens Healthineers to your portfolios can decrease your overall portfolio volatility.